HCPLive Network

Atrial Fibrillation

An examination of the cost-effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation patients.
A recent study published in BMJ Open suggests that taking nonsteroidal anti-inflammatory medications raises the risk of atrial fibrillation.
Although they offer an alternative to warfarin for preventing stroke in patients with atrial fibrillation, effective use of the new anticoagulants requires careful patient selection.
Mitigating the risk of stroke, heart failure, and death when treating patients with atrial fibrillation requires a careful consideration of patient characteristics and management options.
Usage of prescription nonsteroidal anti-inflammatory drugs may increase the risk of atrial fibrillation in older patients, according to the results of a long-term study.
In elderly adults, current and recent non-steroidal anti-inflammatory drug use is associated with increased risk of atrial fibrillation, according to a study published online April 8 in BMJ Open.
Atrial Fibrillation Resources